Literature DB >> 3591616

Heart rate and cardiovascular mortality: the Framingham Study.

W B Kannel, C Kannel, R S Paffenbarger, L A Cupples.   

Abstract

The relation of resting heart rate on biennial ECG examinations to mortality rates over 30 years of follow-up of the Framingham cohort was examined based on 1876 total deaths and 894 cardiovascular deaths, evolving out of 5070 subjects free of cardiovascular disease at entry into the study. In both sexes, at all ages, all-cause, cardiovascular, and coronary mortality rates increased progressively in relation to antecedent heart rates determined biennially. A more impressive association to cardiovascular disease was observed in men than in women, which was independent of associated cardiovascular risk factors. Case fatality rates following coronary events also increased with antecedent heart rate and the fraction of coronary deaths as sudden death increased strikingly with heart rate in men 35 to 64 years of age. There was also a substantial excess of noncardiovascular deaths at high heart rates, and the proportion of all deaths resulting from cardiovascular disease did not increase with heart rate. The excess cardiovascular deaths with more rapid heart rates were also noted, excluding those with interim overt cardiovascular disease, suggesting an effect independent of preexisting cardiac damage.

Entities:  

Mesh:

Year:  1987        PMID: 3591616     DOI: 10.1016/0002-8703(87)90666-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  270 in total

Review 1.  Potential interests of heart rate lowering drugs.

Authors:  T Laperche; D Logeart; A Cohen-Solal; R Gourgon
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 2.  Relevance of heart rate as a risk factor in hypertension.

Authors:  P Palatini; S Julius
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

3.  Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.

Authors:  Ralf Koester; Jan Kaehler; Henning Ebelt; Gerold Soeffker; Karl Werdan; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2010-05-09       Impact factor: 5.460

Review 4.  Advancements in pharmacotherapy for angina.

Authors:  Ankur Jain; Islam Y Elgendy; Mohammad Al-Ani; Nayan Agarwal; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2017-03-15       Impact factor: 3.889

Review 5.  Is heart rate a treatment target in heart failure?

Authors:  Jan-Christian Reil; Michael Böhm
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

6.  Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.

Authors:  Roberto Antonicelli; Stefano Omboni; Di Ciò Giovanni; Roberto Ansuini; Alfredo Mori; Rosaria Gesuita; Gianfranco Parati; Enrico Paciaroni
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 7.  The broken heart: noninvasive measurement of cardiac autonomic tone.

Authors:  S Oppenheimer
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

Review 8.  Role of heart rate as a marker and mediator of poor outcome for patients with heart failure.

Authors:  John R Kapoor; Paul A Heidenreich
Journal:  Curr Heart Fail Rep       Date:  2012-06

9.  The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health.

Authors:  Angela J Grippo
Journal:  Soc Personal Psychol Compass       Date:  2011-04

Review 10.  Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms.

Authors:  Paolo Palatini
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.